Company Information
Ask for more detail from the seller
Contact SupplierVabysmo contains the active ingredient faricimab-svoa. The Food and Drug Administration (FDA) has approved Vabysmo to treat the following eye conditions in adults: wet age-related macular degeneration. diabetic macular edema, which is a complication of diabetes.